new precautions about mood and behavior changes for patients taking Singulair (montelukast) and other leukotriene modifiers

August 2009

You'll see new precautions about mood and behavior changes for patients taking Singulair (montelukast) and other leukotriene modifiers.

This is a surprise. We usually think of Singulair as benign.

But now some patients are reporting insomnia, agitation, anxiety, depression, and similar problems.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote